Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations
暂无分享,去创建一个
Y Li | F. J. White | X. Hu | M. Wolf | Xiu-Ti Hu | F J White | Y. Li | T. G. Berney | A. J. Vartanian | C. Stine | X T Hu | T G Berney | A J Vartanian | C D Stine | M E Wolf | Christy D. Stine | Yong Li | Timothy G. Berney | A. John Vartanian
[1] F. J. White,et al. Dopamine Receptor Antagonists Fail to Prevent Induction of Cocaine Sensitization , 1998, Neuropsychopharmacology.
[2] P. Vezina,et al. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects , 1990, Brain Research.
[3] P. Kalivas,et al. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine , 1997, Neuroscience.
[4] N Clerc,et al. Intrinsic primary afferent neuronsof the intestine , 1998, Progress in Neurobiology.
[5] L. Stinus,et al. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine , 1995, Neuroscience.
[6] J. Steketee,et al. Repeated injection of GBR 12909, but not cocaine or WIN 35,065-2, into the ventral tegmental area induces behavioral sensitization , 1998, Behavioural Brain Research.
[7] S. Cunningham,et al. Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] F. J. White,et al. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronicd-amphetamine treatment , 1984, Brain Research.
[9] P. Kalivas,et al. Robustness of G protein changes in cocaine sensitization shown with immunoblotting , 1993, Synapse.
[10] S. Shibata,et al. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release. , 1996, The Journal of pharmacology and experimental therapeutics.
[11] P Duffy,et al. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[12] A E Kelley,et al. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[13] P. Kalivas,et al. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex , 1993, Neuroscience.
[14] P. Vezina,et al. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. , 1994, The Journal of pharmacology and experimental therapeutics.
[15] F. J. White,et al. Synaptic regulation of mesocorticolimbic dopamine neurons. , 1996, Annual review of neuroscience.
[16] M. Wolf,et al. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants , 1998, Progress in Neurobiology.
[17] P. Kalivas,et al. Neuroadaptations in Ionotropic and Metabotropic Glutamate Receptor mRNA Produced by Cocaine Treatment , 1999, Journal of neurochemistry.
[18] N. Goeders,et al. Cortical dopaminergic involvement in cocaine reinforcement. , 1983, Science.
[19] M. Wolf,et al. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine , 1991, Brain Research.
[20] M. Wolf,et al. Amphetamine and D1 Dopamine Receptor Agonists Produce Biphasic Effects on Glutamate Efflux in Rat Ventral Tegmental Area: Modification by Repeated Amphetamine Administration , 1998, Journal of neurochemistry.
[21] F. J. White,et al. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. , 1995, The Journal of pharmacology and experimental therapeutics.
[22] A. Bonci,et al. A Common Mechanism Mediates Long-Term Changes in Synaptic Transmission after Chronic Cocaine and Morphine , 1996, Neuron.
[23] F. J. White,et al. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. , 1991, The Journal of pharmacology and experimental therapeutics.
[24] S. Amir,et al. Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine , 1994, Brain Research.
[25] D J Henry,et al. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. , 1989, The Journal of pharmacology and experimental therapeutics.
[26] M. Wolf,et al. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization , 1993, Brain Research.
[27] P. Kalivas,et al. Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens , 1987, Brain Research.
[28] D. Henry,et al. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[29] P. Vezina,et al. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine , 1989, Brain Research.
[30] R. Karler,et al. The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine , 1997, Brain Research.
[31] J. MacDonall,et al. Effects of nitric oxide synthase inhibitors on cocaine sensitization , 1997, Brain Research.
[32] H. Davis,et al. Prevention of denervation atrophy in muscle: Mammalian neurotrophic factor is not transferrin , 1984, Brain Research.
[33] R. Wyatt,et al. Chronic cocaine administration increases tyrosine hydroxylase activity in the ventral tegmental area through glutaminergic- and dopaminergic D2-receptor mechanisms , 1996, Neuroscience Letters.
[34] P. Calabresi,et al. Long-term synaptic depression in the striatum: physiological and pharmacological characterization , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] S. Sesack,et al. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area , 1992, The Journal of comparative neurology.
[36] D. L. Davidson,et al. Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. , 1997, The Journal of pharmacology and experimental therapeutics.
[37] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[38] P. Kalivas,et al. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. , 1993, The Journal of pharmacology and experimental therapeutics.
[39] K. Berridge,et al. The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.
[40] P. Overton,et al. Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat , 1995, Brain Research.
[41] S. Young,et al. Glutamate-dependent long-term presynaptic changes in corticostriatal excitability , 1996, Neuroscience.
[42] H. Kuribara,et al. Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice. , 1995, Japanese journal of pharmacology.
[43] T. Ohmori,et al. Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine , 1995, Brain Research.
[44] R. Roth,et al. R-(+)-HA-966, an antagonist for the glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures , 1995, Brain Research.
[45] Y. Itzhak. Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. , 1997, The Journal of pharmacology and experimental therapeutics.
[46] M. Wolf,et al. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex , 1997, Synapse.
[47] S. Dworkin,et al. Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex , 1986, Pharmacology Biochemistry and Behavior.
[48] W. Park,et al. Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. , 1995, The Journal of pharmacology and experimental therapeutics.
[49] H. Kuribara. Modification of cocaine sensitization by dopamine D1 and D2 receptor antagonists in terms of ambulation in mice , 1995, Pharmacology Biochemistry and Behavior.
[50] E. Nestler,et al. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[51] X.-T. Hu,et al. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[52] P. Kalivas,et al. D1 receptors modulate glutamate transmission in the ventral tegmental area , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[53] M. Le Moal,et al. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. , 1996, The Journal of pharmacology and experimental therapeutics.
[54] J. Meador-Woodruff,et al. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems , 1996, Brain Research.
[55] M. Shoaib,et al. Neuroanatomical localization of the effects of (+)-HA966 on locomotor activity after cocaine injections to the nucleus accumbens of rats , 1996, Brain Research.
[56] P. Kalivas,et al. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. , 1988, The Journal of pharmacology and experimental therapeutics.
[57] M. Wolf,et al. Acute and Repeated Systemic Amphetamine Administration: Effects on Extracellular Glutamate, Aspartate, and Serine Levels in Rat Ventral Tegmental Area and Nucleus Accumbens , 1996, Journal of neurochemistry.
[58] J. V. van Rossum,et al. Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. , 1976, European journal of pharmacology.
[59] R. Malenka,et al. Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens , 1994, Nature.
[60] F. J. White,et al. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. , 1993, Behavioural pharmacology.
[61] P. Vezina,et al. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[62] S. Goldberg,et al. Behavioral studies with the glycine partial agonist (+)‐HA966 on cocaine‐induced locomotor activity and reinforcement , 1995, Behavioural pharmacology.
[63] F. J. White,et al. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. , 1997, The Journal of pharmacology and experimental therapeutics.
[64] H. Kuribara,et al. Dopamine Antagonists Can Inhibit Methamphetamine Sensitization, But Not Cocaine Sensitization, When Assessed by Ambulatory Activity in Mice , 1993, The Journal of pharmacy and pharmacology.
[65] F. J. White,et al. Whole-Cell Plasticity in Cocaine Withdrawal: Reduced Sodium Currents in Nucleus Accumbens Neurons , 1998, The Journal of Neuroscience.
[66] M. Wolf,et al. Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex , 1999, Synapse.
[67] N. Hiroi,et al. Regulation of ERK ( Extracellular Signal Regulated Kinase), Part of the Neurotrophin Signal Transduction Cascade, in the Rat Mesolimbic Dopamine System by Chronic Exposure to Morphine or Cocaine , 1996, The Journal of Neuroscience.
[68] E. Nestler,et al. Identification of MARPP-58, a morphine- and cyclic AMP-regulated phosphoprotein of 58 kDa, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[69] Yong Li,et al. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine , 1997, Psychopharmacology.
[70] F. J. White,et al. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment , 1990, Neuroscience Letters.
[71] P. Kalivas,et al. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. , 1996, The Journal of pharmacology and experimental therapeutics.
[72] M. Wolf,et al. Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine , 1997, Behavioural Brain Research.
[73] R. Roth,et al. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract‐tracing study with Phaseolus vulgaris leucoagglutinin , 1989, The Journal of comparative neurology.
[74] E. Nestler,et al. Chronic Cocaine Treatment Decreases Levels of the G Protein Subunits Giα and Goα in Discrete Regions of Rat Brain , 1990 .
[75] B. Mattingly,et al. Cocaine-induced behavioral sensitization: Effects of haloperidol and SCH 23390 treatments , 1996, Pharmacology, Biochemistry and Behavior.
[76] M. Wolf,et al. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: Comparison with N-methyl-d-aspartate antagonists , 1995, Neuroscience.
[77] S. A. Turkanis,et al. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. , 1989, Life sciences.
[78] N. Uretsky,et al. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens , 1989, Neuropharmacology.
[79] S. Schenk,et al. Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus , 1994, Brain Research.
[80] J. MacDonall,et al. Antagonist of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization. , 1995, Life sciences.
[81] J. B. Justice,et al. Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions , 1992, Pharmacology Biochemistry and Behavior.
[82] M. Bozarth,et al. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. , 1993, Life sciences.
[83] F. J. White,et al. MK‐801 prevents the development of behavioral sensitization during repeated morphine administration , 1994, Synapse.